Delivery Order SPE2DB22D2006-SPE2DB24FW0EX
- Not listed
- This is a $19,285.87 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Truvada 200 mg-300 mg tablets, with a completion date of April 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,292.52 firm fixed-price delivery order is for the supply of TRUVADA 200 MG-300 MG tablets. The contract has an ultimate completion date of March 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $3,124.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Truvada 200 mg-300 mg tablets and has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,789.60 firm fixed-price delivery order is for TRUVADA 200 MG-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $13,359.82 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRUVADA 200 MG-300 MG TABLET medication with an ultimate completion date of April 25, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) vehicle held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $24,901.04 order is for the delivery of Truvada 200-300mg tablets and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as the sole awardee. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,906.43 firm fixed price delivery order is for the supply of TRUVADA 200 MG-300 MG TABLET in 30-count units. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,923.04 firm fixed-price contract is for the supply of Truvada 200 mg-300 mg tablets, a prescription medication. There is no set-aside designation for this award. The order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which serves as a primary vehicle for the...
- This is a $10,989.12 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of TRUVADA 200 MG-300 MG TABLET UU 30S. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this and other Indefinite Delivery Contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to provide...
- This is a $14,225.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of TRUVADA 200 MG-300 MG TABLET pharmaceutical products, with a period of performance through April 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025....
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW0EXDelivery Order
This is a $7,172.29 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Truvada 200 mg-300 mg tablet, with a performance period through May 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to DLA facilities supporting the DoD worldwide. Additionally, Amerisourcebergen has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 5/8/24 |